Vaibhav Kumar

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Topics

Chemotherapy Induced

Prognostic Factors

Drug Administration

Small Cell Lung Cancer

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Sandra J Casak, Vaibhav Kumar, Chi Song, Mengdie Yuan, Anup K Amatya, Joyce Cheng, Pallavi S Mishra-Kalyani, Shenghui Tang, Steven J Lemery, Doris Auth, Gina Davis, Paul G Kluetz, Richard Pazdur, Lola A Fashoyin-Aje
FDA Approval Summary: Durvalumab and Pembrolizumab, Immune Checkpoint inhibitors for the Treatment of Biliary Tract Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Sandra J Casak, Vaibhav Kumar, Chi Song, Mengdie Yuan, Anup K Amatya, Joyce Cheng, Pallavi S Mishra-Kalyani, Shenghui Tang, Steven J Lemery, Doris Auth, Gina Davis, Paul G Kluetz, Richard Pazdur, Lola A Fashoyin-Aje
FDA Approval Summary: Durvalumab and Pembrolizumab, Immune Checkpoint Inhibitors for the Treatment of Biliary Tract Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (16) (2024)
Sandra J Casak, Vaibhav Kumar, Chi Song, Mengdie Yuan, Anup K Amatya, Joyce Cheng, Pallavi S Mishra-Kalyani, Shenghui Tang, Steven J Lemery, Doris Auth, Gina Davis, Paul G Kluetz, Richard Pazdur, Lola A Fashoyin-Aje
FDA Approval Summary: Durvalumab and Pembrolizumab, Immune Checkpoint Inhibitors for the Treatment of Biliary Tract Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (16) (2024)
Sandra J Casak, Vaibhav Kumar, Chi Song, Mengdie Yuan, Anup K Amatya, Joyce Cheng, Pallavi S Mishra-Kalyani, Shenghui Tang, Steven J Lemery, Doris Auth, Gina Davis, Paul G Kluetz, Richard Pazdur, Lola A Fashoyin-Aje
FDA Approval Summary: Durvalumab and Pembrolizumab, Immune Checkpoint Inhibitors for the Treatment of Biliary Tract Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (16) (2024)
Vaibhav Kumar, Leslie Doros, Margaret Thompson, Sirisha L Mushti, Rosane Charlab, Elizabeth I Spehalski, Hong Zhao, Matthew D Thompson, Shenghui Tang, Richard Pazdur, Steven J Lemery, Marc R Theoret, Lola A Fashoyin-Aje
FDA Approval Summary: Ripretinib for advanced gastrointestinal stromal tumor. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Vaibhav Kumar, Joseph R Shaw, Nigel S Key, Anton Ilich, Ranjeeta Mallick, Philip S Wells, Marc Carrier
D-Dimer Enhances Risk-Targeted Thromboprophylaxis in Ambulatory Patients with Cancer. The oncologist 25 (12) (2020)